Skip to main content
Smart Investors Daily
BioGaia AB (publ) logo

OTC · BIOGY

BioGaia AB (publ)

Healthcare · Drug Manufacturers - Specialty & Generic

$12.45

Up+$0.00 (+0.00%)

Updated Sep 11, 2026, 9:14 PM

SID Score

4.5/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
1.05B
P/E ratio
31.59
Dividend yield
5.69%
52-week range
— – —
Volume
270
Avg. volume
891

Price performance

BIOGY price history

1M range · 0 trading sessions · Daily adjusted prices

BIOGY does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest BIOGY news

The latest Smart Investors Daily articles mentioning BIOGY.

BIOGY research

Overview

Company profile and research snapshot.

Company profile

BIOGAIA AB S/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$10.84
Implied upside
Analysts
5
BIOGY recent ratings
DateFirmRatingTarget
Jul 5, 2026DNB CARNEGIEBuy
Jun 17, 2026HANDELSBANKEN CAPITAL MARKETSBuy
Feb 16, 2026DNB CARNEGIEBuy
Feb 13, 2026HANDELSBANKEN CAPITAL MARKETSBuy
Jan 14, 2026HANDELSBANKEN CAPITAL MARKETSBuy
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.